Andrew Dalovisio
Overview
Explore the profile of Andrew Dalovisio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahlis N, Costello C, Raje N, Levy M, Dholaria B, Solh M, et al.
Nat Med
. 2023 Oct;
29(10):2570-2576.
PMID: 37783970
Multiple myeloma (MM) is a plasma cell malignancy expressing B cell maturation antigen (BCMA). Elranatamab, a bispecific antibody, engages BCMA on MM and CD3 on T cells. The MagnetisMM-1 trial...
2.
Zeidner J, Lin T, Vigil C, Fine G, Yair Levy M, Nazha A, et al.
Blood Cancer J
. 2021 Oct;
11(10):175.
PMID: 34718324
No abstract available.
3.
Roboz G, Strickland S, Litzow M, Dalovisio A, Perl A, Bonifacio G, et al.
Leuk Lymphoma
. 2020 Aug;
61(13):3146-3153.
PMID: 32812818
Approval of midostaurin, a multikinase inhibitor, in combination with chemotherapy for the treatment of adults with newly diagnosed mutation-positive acute myeloid leukemia, was based on the phase 3 RATIFY trial...
4.
Blackburn P, Huang L, Dalovisio A, Pitel B, Chen D, Oliveira J, et al.
Cancer Genet
. 2020 Jan;
241:67-71.
PMID: 31902694
Secondary acquisition of t(9;22)(q34;q11.2)/BCR-ABL1 fusion in the context of de novo acute myeloid leukemia (AML) with inv(3)(q21q26)/GATA2-MECOM rearrangement has been rarely reported. Furthermore, t(2;11)(p23;q23)/KMT2A-ASXL2 fusion has been rarely described with...
5.
Finn L, Dalovisio A, Foran J
Ochsner J
. 2017 Dec;
17(4):398-404.
PMID: 29230125
Background: Even though acute myeloid leukemia (AML) occurs most commonly in adults ≥60 years, the treatment of AML in older patients remains a significant challenge. Methods: We reviewed the current...
6.
Karmali R, Dalovisio A, Borgia J, Venugopal P, Kim B, Grant-Szymanski K, et al.
Blood Rev
. 2014 Dec;
29(2):71-80.
PMID: 25433571
Metabolic syndrome constitutes a constellation of findings including central obesity, insulin resistance/type 2 diabetes mellitus (DM), dyslipidemia and hypertension. Metabolic syndrome affects 1 in 4 adults in the United States...